| CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis M Todaro, M Gaggianesi, V Catalano, A Benfante, F Iovino, M Biffoni, ... Cell stem cell 14 (3), 342-356, 2014 | 829 | 2014 |
| Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): sensitivity analysis of trials in … L Carbognin, S Pilotto, M Milella, V Vaccaro, M Brunelli, A Caliò, ... PloS one 10 (6), e0130142, 2015 | 536 | 2015 |
| Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect E Salvati, C Leonetti, A Rizzo, M Scarsella, M Mottolese, R Galati, ... The Journal of clinical investigation 117 (11), 3236-3247, 2007 | 301 | 2007 |
| Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases M Cosimelli, R Golfieri, PP Cagol, L Carpanese, R Sciuto, CL Maini, ... British journal of cancer 103 (3), 324-331, 2010 | 276 | 2010 |
| Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution R Sciuto, L Romano, S Rea, F Marandino, I Sperduti, CL Maini Annals of Oncology 20 (10), 1728-1735, 2009 | 225 | 2009 |
| Seven‐point checklist of dermoscopy revisited G Argenziano, C Catricalà, M Ardigo, P Buccini, P De Simone, ... British Journal of Dermatology 164 (4), 785-790, 2011 | 218 | 2011 |
| Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial C Garufi, A Torsello, S Tumolo, GM Ettorre, M Zeuli, C Campanella, ... British journal of cancer 103 (10), 1542-1547, 2010 | 205 | 2010 |
| Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials E Bria, F Cuppone, M Fornier, C Nisticò, P Carlini, M Milella, I Sperduti, ... Breast cancer research and treatment 109, 231-239, 2008 | 203 | 2008 |
| FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer M Milella New England Journal of Medicine, 768-769, 2011 | 202 | 2011 |
| Immunohistochemical expression of p16INK4a is predictive of HR-HPV infection in cervical low-grade lesions M Benevolo, M Mottolese, F Marandino, G Vocaturo, R Sindico, G Piperno, ... Modern Pathology 19 (3), 384-391, 2006 | 192 | 2006 |
| Arterial access-site–related outcomes of patients undergoing invasive coronary procedures for acute coronary syndromes (from the ComPaRison of Early Invasive and Conservative … A Sciahbasi, C Pristipino, G Ambrosio, I Sperduti, EV Scabbia, C Greco, ... The American journal of cardiology 103 (6), 796-800, 2009 | 172 | 2009 |
| Triple positive breast cancer: a distinct subtype? P Vici, L Pizzuti, C Natoli, T Gamucci, L Di Lauro, M Barba, D Sergi, ... Cancer treatment reviews 41 (2), 69-76, 2015 | 158 | 2015 |
| Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability MS Pino, H Kikuchi, M Zeng, MT Herraiz, I Sperduti, D Berger, DY Park, ... Gastroenterology 138 (4), 1406-1417, 2010 | 153 | 2010 |
| Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center A Fabi, A Felici, G Metro, A Mirri, E Bria, S Telera, L Moscetti, M Russillo, ... Journal of experimental & clinical cancer research 30, 1-7, 2011 | 152 | 2011 |
| Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer B Tomaino, P Cappello, M Capello, C Fredolini, I Sperduti, P Migliorini, ... Journal of proteome research 10 (1), 105-112, 2011 | 141 | 2011 |
| Extended multiorgan resection for T4 gastric carcinoma: 25‐year experience F Carboni, P Lepiane, R Santoro, R Lorusso, P Mancini, I Sperduti, ... Journal of surgical oncology 90 (2), 95-100, 2005 | 140 | 2005 |
| Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers-Danlos syndrome, hypermobility type) M Castori, I Sperduti, C Celletti, F Camerota, P Grammatico Clin Exp Rheumatol 29 (6), 998-1005, 2011 | 135 | 2011 |
| HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care A Fabi, A Di Benedetto, G Metro, L Perracchio, C Nisticò, F Di Filippo, ... Clinical Cancer Research 17 (7), 2055-2064, 2011 | 133 | 2011 |
| Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas MS Pino, M Mino-Kenudson, BM Wildemore, A Ganguly, J Batten, ... The Journal of Molecular Diagnostics 11 (3), 238-247, 2009 | 131 | 2009 |
| A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study F Novelli, M Milella, E Melucci, A Di Benedetto, I Sperduti, ... Breast Cancer Research 10, 1-12, 2008 | 131 | 2008 |
